Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples